AI Portfolio Summary
In 2026 Q1, Andera Partners maintained a portfolio of 7 distinct positions. The most significant new addition to the portfolio was AGOMAB THERAPEUTICS , which now represents 9.12% of the total fund value. They heavily accumulated shares in KESTRA MED TECHNOLOG, increasing their position by 6.1%.
Total Positions
7
Quarter
2026 Q1
Top Holding
KMTS (30.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-7 of 7
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KMTS
KESTRA MED TECH...
|
Healthcare | 30.36% | 38.14% |
#1
Prev: #1
|
8.0 | 155,086 | 6.1% |
P
S
|
2,695,192 | $53,715,177 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-11 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 24.66% | 18.39% |
#2
1
Prev: #3
|
6.5 | no change | no change |
P
S
|
1,897,362 | $43,620,352 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-11 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 24.38% | 32.71% |
#3
1
Prev: #2
|
6.0 | no change | no change |
P
S
|
1,591,917 | $43,125,032 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-11 | |||
|
N/A
AGOMAB THERAPEU...
|
—
|
Unknown | 9.12% | — |
#4
Prev: #—
|
7.6 | 1,538,702 | no change |
NEW
|
1,538,702 | $16,140,984 | — | 13F Filing | 2026-03-31 | 2026-05-11 | ||
|
IVA
INVENTIVA SA
|
Healthcare | 5.70% | 4.79% |
#5
Prev: #5
|
3.8 | no change | no change |
P
S
|
1,818,181 | $10,090,905 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-11 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 4.92% | 5.97% |
#6
2
Prev: #4
|
3.0 | no change | no change |
P
S
|
78,125 | $8,699,219 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-11 | |||
|
NYXH
NYXOAH S A
|
Healthcare | 0.86% | — |
#7
Prev: #—
|
3.8 | 522,057 | no change |
NEW
|
522,057 | $1,524,406 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-11 |
Showing 1-7 of 7 holdings